Welcome to LookChem.com Sign In|Join Free

CAS

  • or

921592-86-1

Post Buying Request

921592-86-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

921592-86-1 Usage

Chemical structure

The compound consists of a pyrrolidine ring attached to a pyridine ring with an amino group at the 5th position of the pyridine ring.

Chirality

It is a chiral compound, meaning it has a handedness or asymmetry in its molecular structure.

Enantiomers

Different enantiomers (mirror images) of chiral compounds can have different effects in the body.

Pharmaceutical applications

It has potential pharmaceutical applications due to its structure and interaction with biological systems.

Biological activity

The compound may have biological activity in the body, which can be influenced by its chirality.

Drug development

Understanding and controlling the chirality of 1-(5-amino-2-pyridinyl)-3-(R)-pyrrolidinol is important in drug development and medicinal chemistry.

Stereochemistry

The compound has an (R)-configuration at the 3rd position, which is crucial for its potential biological activity and pharmaceutical applications.

Molecular weight

The molecular weight of the compound is approximately 150.23 g/mol.

Solubility

The compound's solubility in water and other solvents can be influenced by its chirality and the presence of functional groups.

Stability

The stability of the compound under various conditions (e.g., temperature, pH, light exposure) can be affected by its chirality and molecular structure.

Synthesis

The synthesis of 1-(5-amino-2-pyridinyl)-3-(R)-pyrrolidinol may involve multiple steps, including the formation of the pyrrolidine and pyridine rings, and the introduction of the amino group at the 5th position.

Purification

The purification of the compound may require techniques such as chromatography to separate enantiomers and remove impurities.

Characterization

Techniques like nuclear magnetic resonance (NMR), mass spectrometry (MS), and infrared (IR) spectroscopy can be used to confirm the structure and purity of the compound.

Safety and handling

Proper safety measures should be taken when handling 1-(5-amino-2-pyridinyl)-3-(R)-pyrrolidinol, including the use of personal protective equipment (PPE) and following good laboratory practices.

Check Digit Verification of cas no

The CAS Registry Mumber 921592-86-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,1,5,9 and 2 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 921592-86:
(8*9)+(7*2)+(6*1)+(5*5)+(4*9)+(3*2)+(2*8)+(1*6)=181
181 % 10 = 1
So 921592-86-1 is a valid CAS Registry Number.

921592-86-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (3R)-1-(5-aminopyridin-2-yl)pyrrolidin-3-ol

1.2 Other means of identification

Product number -
Other names 3-Pyrrolidinol,1-(5-amino-2-pyridinyl)-,(3R)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:921592-86-1 SDS

921592-86-1Relevant articles and documents

SUBSTITUTED HETEROAROMATIC PYRAZOLE-CONTAINING CARBOXAMIDE AND UREA DERIVATIVES AS VANILLOID RECEPTOR LIGANDS

-

, (2013/03/26)

The invention relates to substituted heteroaromatic pyrazole-containing carboxamide and urea derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

THERAPEUTIC AGENTS

-

Page/Page column 26, (2010/11/25)

Compounds of formula (I), processes for preparing such compounds, their use in the treatment of obesity, psychiatric disorders, cognitive disorders, memory disorders, schizophrenia, epilepsy, and related conditions, and neurological disorders such as dementia, multiple sclerosis, Parkinson's disease, Huntington's chorea and Alzheimer's disease and pain related disorders and to pharmaceutical compositions containing them.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 921592-86-1